The Patent Finder
US

Methods of Treating Eosinophilic Esophagitis

US 12,059,494 In force
OverviewFamilyAssignmentsSources & methods

Term ends Aug 18, 2037 · Low confidence

Filed Sep 11, 2023 as application 18/244,500 · Granted Aug 13, 2024
Base term, 20 years from filing
Today
20 years from filing
2017 2037
Clock starts
Aug 18, 2017
Term ends
Aug 18, 2037
Granted
Aug 13, 2024
base term Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,026,887, US 11,684,571, US 11,896,710, to Aug 18, 2037. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 18, 2017, when application 15/680,301, the earliest non-provisional in its chain, was filed (this one was filed Sep 11, 2023); a parent in its chain could not be resolved (the next row)Aug 18, 2037High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 11,026,887, US 11,684,571, US 11,896,710)resolves to Aug 18, 2037, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 17376996, 16992671, 16131812, 15680301Low confidence overallLow confidence
Computed term endThe steps above, in orderAug 18, 2037Low confidence

This family

US 10,105,315In force
Aug 2037
Aug 2037
US 11,026,887In force
Aug 2037
Aug 2037
Application 16/992,671Abandoned
not computed
not computed
US 11,684,571In force
Aug 2037
Aug 2037
US 11,896,710In force
Aug 2037
Aug 2037
US 12,059,494this patent
Aug 2037
Aug 2037
Application 18/755,113Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 10, 2024
Reel 66086, frame 826
Meltzer, Brian A.; Comer, Gail M.Adare Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 12, 2024
Reel 66109, frame 612
Adare Pharmaceuticals, Inc.Adare Development I, L.p.Assignment of Assignor's Interest
Jan 12, 2024
Reel 66565, frame 254
Meltzer, Brian; Comer, GailAdare Pharmaceuticals, Inc.Corrective Assignment to Correct the the First Inventor's Execution Date Previously Recorded at Reel: 66086 Frame: 826. Assignor(S) Hereby Confirms the Assignment.
Jan 17, 2024
Reel 66342, frame 759
Adare Development I, L.p.Adare Pharmaceuticals US, L.P.Change of Name
Mar 1, 2024
Reel 66724, frame 537
Adare Pharmaceuticals US, L.P.Ellodi Pharmaceuticals, L.p.Change of Name
Jun 18, 2024
Reel 67759, frame 983
Eagle, GinaEllodi Pharmaceuticals, L.p.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited